12.47USDMkt Cap: 911.06M $P/E: —1d ago
Cybin Inc., doing business as Helus Pharma, a clinical stage pharmaceutical company, focuses on developing therapies to treat various psychiatric and neurological conditions.It develops HLP003, a deuterated psilocybin an…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap911.06M $
Enterprise Value1.58B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-148.00M $
Revenue/Share—
Last Price12.47 USD
Fiscal Year EndMar 2026
MR QuarterOct 2020
Employees100
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.82
PEG—
EV/EBITDA-11.06
EV/Revenue—
P/S—
P/B234.23
EPS (TTM)-4.06
EPS (Forward)-1.83
52W Range
12.0265% of range12.71
52W High12.71 USD
52W Low12.02 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-63.85%
ROA-58.92%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-133.27M $
CapEx (TTM)1.37M $
FCF Margin—
FCF Yield-9.06%
Net Debt-206.36K $
Net Debt/EBITDA0.00
Balance Sheet
Debt/Equity—
Current Ratio9.52
Quick Ratio8.38
Book Value/Sh0.0532 USD
Cash/Share0.0020 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:38
Split DateSep 19, 2024
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)41.67 USD
Upside (mean)+234.2%
Target Range15.39 USD – 70.58 USD
$15.39+234.2% to mean$70.58
# Analysts9
Ownership
Shares Out.73.06M
Float99.34M
Insiders2.74%
Institutions46.89%
Short Interest
Short Ratio2.0d
Short % Out.5.09%
Shares Short3.26M
Short (prev mo.)3.00M
Technical
SMA 507.425 (+68.0%)
SMA 2006.374 (+95.6%)
Beta0.56
S&P 52W Chg21.00%
Avg Vol (30d)1.82M
Avg Vol (10d)1.92M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—